| Literature DB >> 28915835 |
Syunsuke Araki1, Atsushi Miki2,3, Katsutoshi Goto1, Tsutomu Yamashita1,4, Go Takizawa1, Kazuko Haruishi1, Yoshiaki Ieki1, Junichi Kiryu1, Kiyoshi Yaoeda5.
Abstract
BACKGROUND: To investigate macular retinal and choroidal thickness in amblyopic eyes compared to that in fellow and normal eyes using swept-source optical coherence tomography (SS-OCT).Entities:
Keywords: Amblyopia; Choroidal thickness; Optical coherence tomography; Retinal thickness
Mesh:
Year: 2017 PMID: 28915835 PMCID: PMC5602831 DOI: 10.1186/s12886-017-0559-3
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Fig. 1Retinal and choroidal thickness determined by swept-source optical coherence tomography. The retinal and choroidal thicknesses measured included (a) macular retinal nerve fiber layer, (b) ganglion cell layer + inner plexiform layer, (c) ganglion cell complex, (d) inner limiting membrane to the retinal pigment epithelium, and (e) choroidal thickness
Fig. 2Analyzed regions of retinal and choroidal thickness using the Early Treatment Diabetic Retinopathy Study map. Three concentric macular regions were defined, with radii of 0.5 mm (center 1 mm), 0.5 to 1.5 mm (inner ring), and 1.5 to 3.0 mm (outer ring). Inner and outer rings were divided into four quadrants: superior, nasal, inferior, and temporal. Foveal minimum thickness and subfoveal choroidal thickness were also analyzed
Demographic and clinical data for the amblyopia groups and the normal control group
| Anisometropic Group ( | Strabismic Group ( | Normal control Group ( | |||
|---|---|---|---|---|---|
| AE | FE | AE | FE | NE | |
| Age | 6.9 ± 3.8 (3 to 18) | 7.9 ± 4.2 (4 to 21) | 7.8 ± 3.3 (3 to 16) | ||
| Gender (Male : Female) | 13 : 18 | 6 : 9 | 9 : 15 | ||
| Visual acuity (logMAR) | 0.31 ± 0.22 | -0.12 ± 0.08 | 0.16 ± 0.09 | -0.10 ± 0.08 | -0.12 ± 0.07 |
| (1.00 to 0.10) | (0.00 to -0.18) | (0.40 to 0.10) | (0.00 to -0.18) | (0.00 to -0.18) | |
| Refraction (diopter) | 5.02 ± 1.79 | 2.07 ± 1.79 | 3.28 ± 3.16 | 2.87 ± 3.10 | 0.44 ± 1.17 |
| (1.00 to 8.00) | (-1.00 to 5.25) | (-2.75 to 7.00) | (-3.25 to 6.75) | (-1.75 to 3.25) | |
| Axial length (mm) | 21.20 ± 0.95 | 22.21 ± 1.10 | 21.97 ± 1.17 | 21.99 ± 1.17 | 22.74 ± 1.06 |
| (19.61 to 23.89) | (20.73 to 24.91) | (20.30 to 24.42) | (20.40 to 24.08) | (20.85 to 24.61) | |
AE: Amblyopic eyes; FE: Fellow eyes; NE: Normal control eyes
Values are shown as mean ± standard deviation (range)
mRNFL thickness in the anisometropic amblyopia and normal control eyes
| Anisometropic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| ETDRS maps | ||||||
| Center 1 mm | 2.2 ± 1.7 | 2.5 ± 1.8 | 2.8 ± 1.9 | 0.35 | 0.81 | 0.99 |
| Inner ring (1-3 mm) | ||||||
| Superior | 26.4 ± 3.0 | 27.0 ± 3.3 | 28.7 ± 2.1 | 0.069 | 0.71 | 0.21 |
| Nasal | 20.6 ± 3.9 | 22.4 ± 2.8 | 24.3 ± 1.7 | 0.87 | 0.14 | 0.13 |
| Inferior | 26.6 ± 3.5 | 28.0 ± 4.0 | 29.4 ± 2.9 | 0.18 | 0.89 | 0.92 |
| Temporal | 20.2 ± 2.8 | 21.0 ± 2.6 | 22.1 ± 1.9 | 0.44 | 0.35 | 0.27 |
| Outer ring (3-6 mm) | ||||||
| Superior | 40.6 ± 4.8 | 42.7 ± 4.8 | 42.1 ± 3.7 | 0.60 | 0.81 | 0.19 |
| Nasal | 46.6 ± 7.5 | 50.0 ± 7.7 | 50.9 ± 5.3 | 0.71 | 0.90 | 0.66 |
| Inferior | 41.6 ± 4.6 | 43.5 ± 5.6 | 43.3 ± 5.4 | 0.98 | 0.86 | 0.45 |
| Temporal | 24.2 ± 2.6 | 24.9 ± 2.6 | 25.8 ± 2.2 | 0.62 | 0.71 | 0.33 |
| Center 6 mm | 27.7 ± 2.9 | 29.1 ± 3.1 | 29.9 ± 1.9 | 0.59 | 0.50 | 0.96 |
mRNFL thickness in the strabismic amblyopia and normal control eyes
| Strabismic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| ETDRS maps | ||||||
| Center 1 mm | 3.5 ± 2.7 | 3.5 ± 3.5 | 2.8 ± 1.9 | 0.94 | 0.62 | 0.15 |
| Inner ring (1-3 mm) | ||||||
| Superior | 27.9 ± 3.7 | 28.1 ± 2.8 | 28.7 ± 2.1 | 0.82 | 0.87 | 0.76 |
| Nasal | 24.2 ± 4.1 | 23.9 ± 3.1 | 24.3 ± 1.7 | 0.71 | 0.28 | 0.49 |
| Inferior | 28.7 ± 3.4 | 28.7 ± 4.1 | 29.4 ± 2.9 | 0.98 | 0.67 | 0.44 |
| Temporal | 21.6 ± 1.8 | 20.9 ± 3.2 | 22.1 ± 1.9 | 0.62 | 0.27 | 0.73 |
| Outer ring (3-6 mm) | ||||||
| Superior | 40.1 ± 4.8 | 39.9 ± 2.5 | 42.1 ± 3.7 | 0.87 | 0.62 | 0.78 |
| Nasal | 53.1 ± 10.4 | 50.7 ± 9.6 | 50.9 ± 5.3 | 0.44 | 0.10 | 0.36 |
| Inferior | 42.8 ± 6.3 | 44.3 ± 8.6 | 43.3 ± 5.4 | 0.55 | 0.45 | 0.21 |
| Temporal | 24.9 ± 1.9 | 24.7 ± 2.8 | 25.8 ± 2.2 | 0.63 | 0.16 | 0.49 |
| Center 6 mm | 29.6 ± 3.7 | 29.4 ± 3.8 | 29.9 ± 1.9 | 0.82 | 0.49 | 0.62 |
AE: Amblyopic eyes; FE: Fellow eyes; NE: Normal control eyes; ETDRS: early treatment diabetic retinopathy study; AL: axial length
a ANCOVA; ** p < 0.01; * p < 0.05
Values are shown as mean ± standard deviation (μm)
GCL+IPL thickness in the anisometropic amblyopia and normal control eyes
| Anisometropic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| ETDRS maps | ||||||
| Center 1 mm | 40.0 ± 7.0 | 41.8 ± 7.0 | 44.5 ± 6.3 | 0.77 | 0.41 | 0.38 |
| Inner ring (1-3 mm) | ||||||
| Superior | 90.4 ± 5.3 | 90.8 ± 5.9 | 91.1 ± 4.7 | 0.069 | 0.053 | 0.68 |
| Nasal | 90.6 ± 5.6 | 91.6 ± 6.7 | 92.9 ± 4.9 | 0.11 | 0.059 | 0.93 |
| Inferior | 90.6 ± 5.7 | 91.2 ± 6.5 | 90.8 ± 5.1 | 0.10 | 0.23 | 0.29 |
| Temporal | 86.0 ± 7.1 | 87.1 ± 6.2 | 87.8 ± 5.2 | 0.062 | 0.24 | 0.55 |
| Outer ring (3-6 mm) | ||||||
| Superior | 70.6 ± 6.3 | 67.4 ± 5.0 | 64.6 ± 5.9 | 0.11 | 0.21 | 0.35 |
| Nasal | 77.1 ± 7.2 | 73.0 ± 5.3 | 70.0 ± 6.6 | 0.24 | 0.18 | 0.21 |
| Inferior | 68.9 ± 8.5 | 64.1 ± 5.5 | 61.7 ± 7.1 | 0.26 | 0.26 | 0.45 |
| Temporal | 75.0 ± 6.5 | 72.7 ± 5.5 | 70.0 ± 5.7 | 0.43 | 0.41 | 0.87 |
| Center 6 mm | 76.6 ± 4.3 | 75.5 ± 3.9 | 74.8 ± 4.2 | 0.24 | 0.58 | 0.080 |
GCL+IPL thickness in the strabismic amblyopia and normal control eyes
| Strabismic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| ETDRS maps | ||||||
| Center 1 mm | 43.5 ± 9.3 | 45.1 ± 12.1 | 44.5 ± 6.3 | 0.65 | 0.63 | 0.27 |
| Inner ring (1-3 mm) | ||||||
| Superior | 91.4 ± 5.3 | 91.6 ± 5.2 | 91.1 ± 4.7 | 0.88 | 0.93 | 0.79 |
| Nasal | 93.3 ± 7.0 | 92.7 ± 6.2 | 92.9 ± 4.9 | 0.96 | 0.29 | 0.23 |
| Inferior | 92.7 ± 5.3 | 90.9 ± 5.7 | 90.8 ± 5.1 | 0.32 | 0.18 | 0.29 |
| Temporal | 87.0 ± 5.6 | 87.5 ± 6.4 | 87.8 ± 5.2 | 0.83 | 0.78 | 0.49 |
| Outer ring (3-6 mm) | ||||||
| Superior | 67.7 ± 6.4 | 69.0 ± 7.9 | 64.6 ± 5.9 | 0.97 | 0.98 | 0.98 |
| Nasal | 72.1 ± 8.1 | 75.5 ± 8.1 | 70.0 ± 6.6 | 0.19 | 0.88 | 0.15 |
| Inferior | 63.0 ± 6.5 | 65.9 ± 7.9 | 61.7 ± 7.1 | 0.17 | 0.80 | 0.43 |
| Temporal | 71.1 ± 5.4 | 73.0 ± 5.4 | 70.0 ± 5.7 | 0.83 | 0.30 | 0.21 |
| Center 6 mm | 75.8 ± 3.7 | 76.8 ± 3.7 | 74.8 ± 4.2 | 0.94 | 0.73 | 0.67 |
AE: Amblyopic eyes; FE: Fellow eyes; NE: Normal control eyes; ETDRS: early treatment diabetic retinopathy study; AL: axial length
a ANCOVA; ** p < 0.01; * p < 0.05
Values are shown as mean ± standard deviation (μm)
GCC thickness in the anisometropic amblyopia and normal control eyes
| Anisometropic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| ETDRS maps | ||||||
| Center 1 mm | 42.4 ± 7.8 | 44.3 ± 7.5 | 47.3 ± 7.6 | 0.62 | 0.56 | 0.46 |
| Inner ring (1-3 mm) | ||||||
| Superior | 116.7 ± 7.4 | 117.7 ± 8.1 | 119.8 ± 5.7 | 0.33 | 0.74 | 0.89 |
| Nasal | 111.8 ± 8.6 | 113.7 ± 8.8 | 117.1 ± 5.8 | 0.071 | 0.84 | 0.42 |
| Inferior | 117.2 ± 8.1 | 119.2 ± 9.8 | 120.2 ± 6.5 | 0.076 | 0.52 | 0.46 |
| Temporal | 105.7 ± 7.8 | 108.3 ± 7.6 | 110.0 ± 5.9 | 0.16 | 0.83 | 0.85 |
| Outer ring (3-6 mm) | ||||||
| Superior | 110.8 ± 7.8 | 110.2 ± 7.6 | 106.6 ± 8.0 | 0.73 | 0.68 | 0.24 |
| Nasal | 123.9 ± 7.6 | 122.9 ± 7.9 | 121.0 ± 9.0 | 0.17 | 0.43 | 0.11 |
| Inferior | 110.5 ± 8.7 | 107.6 ± 7.3 | 104.9 ± 10.5 | 0.36 | 0.83 | 0.59 |
| Temporal | 99.2 ± 7.6 | 97.7 ± 6.6 | 95.8 ± 6.6 | 0.18 | 0.33 | 0.80 |
| Center 6 mm | 104.2 ± 5.8 | 104.6 ± 6.2 | 104.7 ± 5.3 | 0.11 | 0.38 | 0.48 |
GCC thickness in the strabismic amblyopia and normal control eyes
| Strabismic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| ETDRS maps | ||||||
| Center 1 mm | 47.2 ± 11.5 | 48.7 ± 14.8 | 47.3 ± 7.6 | 0.73 | 0.37 | 0.18 |
| Inner ring (1-3 mm) | ||||||
| Superior | 119.3 ± 6.8 | 119.7 ± 6.8 | 119.8 ± 5.7 | 0.90 | 0.65 | 0.23 |
| Nasal | 118.2 ± 8.5 | 117.1 ± 8.6 | 117.1 ± 5.8 | 0.65 | 0.26 | 0.47 |
| Inferior | 121.3 ± 7.7 | 119.3 ± 8.7 | 120.2 ± 6.5 | 0.42 | 0.18 | 0.57 |
| Temporal | 108.7 ± 6.5 | 108.4 ± 7.4 | 110.0 ± 5.9 | 0.89 | 0.86 | 0.92 |
| Outer ring (3-6 mm) | ||||||
| Superior | 107.7 ± 7.2 | 107.7 ± 5.5 | 106.6 ± 8.0 | 0.52 | 0.87 | 0.99 |
| Nasal | 125.1 ± 8.3 | 125.0 ± 7.3 | 121.0 ± 9.0 | 0.85 | 0.69 | 0.54 |
| Inferior | 105.7 ± 7.4 | 110.1 ± 8.2 | 104.9 ± 10.5 | 0.90 | 0.83 | 0.75 |
| Temporal | 96.3 ± 5.3 | 97.8 ± 5.6 | 95.8 ± 6.6 | 0.61 | 0.57 | 0.31 |
| Center 6 mm | 105.5 ± 5.3 | 106.0 ± 5.6 | 104.7 ± 5.3 | 0.81 | 0.43 | 0.36 |
AE: Amblyopic eyes; FE: Fellow eyes; NE: Normal control eyes; ETDRS: early treatment diabetic retinopathy study; AL: axial length
a ANCOVA; ** p < 0.01; * p < 0.05
Values are shown as mean ± standard deviation (μm)
ILM-RPE thickness in the anisometropic amblyopia and normal control eyes
| Anisometropic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| FMT | 181.6 ± 13.1 | 180.4 ± 13.0 | 186.1 ± 15.1 | 0.17 | 0.98 | 0.35 |
| ETDRS maps | ||||||
| Center 1 mm | 218.9 ± 16.3 | 219.6 ± 14.8 | 226.2 ± 18.8 | 0.21 | 0.62 | 0.47 |
| Inner ring (1-3 mm) | ||||||
| Superior | 310.6 ± 13.1 | 306.5 ± 12.3 | 309.0 ± 12.3 | 0.020* | 0.094 | 0.073 |
| Nasal | 308.8 ± 14.9 | 305.9 ± 13.9 | 309.4 ± 14.1 | 0.047* | 0.083 | 0.061 |
| Inferior | 307.1 ± 13.9 | 303.6 ± 13.6 | 304.7 ± 10.9 | 0.032* | 0.46 | 0.82 |
| Temporal | 297.2 ± 14.3 | 295.0 ± 12.1 | 297.1 ± 12.3 | 0.059 | 0.21 | 0.15 |
| Outer ring (3-6 mm) | ||||||
| Superior | 285.7 ± 13.4 | 278.2 ± 12.6 | 274.9 ± 14.8 | 0.065 | 0.59 | 0.22 |
| Nasal | 300.3 ± 13.2 | 291.2 ± 11.9 | 288.6 ± 16.1 | 0.32 | 0.35 | 0.10 |
| Inferior | 275.5 ± 14.7 | 265.6 ± 12.4 | 263.0 ± 15.5 | 0.13 | 0.45 | 0.85 |
| Temporal | 271.9 ± 13.3 | 263.2 ± 13.2 | 261.9 ± 12.2 | 0.16 | 0.32 | 0.73 |
| Center 6 mm | 286.6 ± 11.4 | 279.3 ± 10.4 | 278.1 ± 12.2 | 0.22 | 0.37 | 0.16 |
ILM-RPE thickness in the strabismic amblyopia and normal control eyes
| Strabismic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| FMT | 187.7 ± 20.2 | 193.5 ± 24.6 | 186.1 ± 15.1 | 0.35 | 0.17 | 0.062 |
| ETDRS maps | ||||||
| Center 1 mm | 228.5 ± 22.4 | 229.0 ± 25.3 | 226.2 ± 18.8 | 0.97 | 0.30 | 0.26 |
| Inner ring (1-3 mm) | ||||||
| Superior | 313.1 ± 12.9 | 312.7 ± 13.7 | 309.0 ± 12.3 | 0.97 | 0.89 | 0.86 |
| Nasal | 315.1 ± 13.5 | 312.9 ± 13.2 | 309.4 ± 14.1 | 0.72 | 0.36 | 0.19 |
| Inferior | 311.0 ± 11.9 | 307.7 ± 11.9 | 304.7 ± 10.9 | 0.46 | 0.95 | 0.88 |
| Temporal | 300.0 ± 11.6 | 298.1 ± 12.9 | 297.1 ± 12.3 | 0.97 | 0.90 | 0.88 |
| Outer ring (3-6 mm) | ||||||
| Superior | 281.4 ± 12.9 | 279.9 ± 13.3 | 274.9 ± 14.8 | 0.73 | 0.57 | 0.90 |
| Nasal | 298.7 ± 13.8 | 300.4 ± 13.0 | 288.6 ± 16.1 | 0.69 | 0.28 | 0.13 |
| Inferior | 267.8 ± 12.9 | 274.4 ± 14.6 | 263.0 ± 15.5 | 0.11 | 0.95 | 0.17 |
| Temporal | 266.3 ± 12.0 | 267.8 ± 12.9 | 261.9 ± 12.2 | 0.59 | 0.68 | 0.51 |
| Center 6 mm | 284.1 ± 10.8 | 285.3 ± 11.0 | 278.1 ± 12.2 | 0.73 | 0.45 | 0.30 |
AE: Amblyopic eyes; FE: Fellow eyes; NE: Normal control eyes; FMT: foveal minimum thickness; ETDRS: early treatment diabetic retinopathy study; AL: axial length
a ANCOVA; ** p < 0.01; * p < 0.05
Values are shown as mean ± standard deviation (μm)
Choroidal thickness in the anisometropic amblyopia and normal control eyes
| Anisometropic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| SFCT | 320.8 ± 55.3 | 274.0 ± 55.2 | 274.7 ± 52.8 | 0.016* | 0.017* | 0.85 |
| ETDRS maps | ||||||
| Center 1 mm | 320.2 ± 53.1 | 274.0 ± 53.3 | 277.4 ± 51.6 | 0.011* | 0.044* | 0.33 |
| Inner ring (1-3 mm) | ||||||
| Superior | 306.2 ± 44.2 | 275.5 ± 52.7 | 279.6 ± 50.1 | 0.005** | 0.080 | 0.31 |
| Nasal | 301.7 ± 53.5 | 244.7 ± 60.4 | 247.7 ± 51.5 | 0.013* | 0.007** | 0.33 |
| Inferior | 317.4 ± 51.4 | 265.3 ± 55.7 | 275.3 ± 45.3 | 0.005** | 0.039* | 0.18 |
| Temporal | 319.6 ± 51.4 | 286.8 ± 46.3 | 293.1 ± 54.8 | 0.037* | 0.21 | 0.28 |
| Outer ring (3-6 mm) | ||||||
| Superior | 293.6 ± 36.4 | 261.6 ± 45.0 | 265.0 ± 48.8 | 0.056 | 0.396 | 0.37 |
| Nasal | 251.1 ± 51.1 | 187.0 ± 59.9 | 185.7 ± 46.7 | 0.045* | 0.003** | 0.49 |
| Inferior | 287.1 ± 49.1 | 249.1 ± 46.3 | 260.4 ± 42.9 | 0.022* | 0.41 | 0.16 |
| Temporal | 299.8 ± 49.3 | 278.7 ± 42.0 | 286.6 ± 54.2 | 0.21 | 0.84 | 0.37 |
| Center 6 mm | 290.2 ± 41.6 | 250.3 ± 44.5 | 255.7 ± 44.9 | 0.015* | 0.049* | 0.26 |
Choroidal thickness in the strabismic amblyopia and normal control eyes
| Strabismic amblyopia |
| |||||
|---|---|---|---|---|---|---|
| AE ( | FE ( | NE ( | AE vs FE | AE vs NE | FE vs NE | |
| SFCT | 293.1 ± 74.3 | 274.1 ± 75.8 | 274.7 ± 52.8 | 0.78 | 0.94 | 0.78 |
| ETDRS maps | ||||||
| Center 1 mm | 293.3 ± 68.1 | 279.0 ± 65.8 | 277.4 ± 51.6 | 0.99 | 0.92 | 0.90 |
| Inner ring (1-3 mm) | ||||||
| Superior | 268.1 ± 40.3 | 287.6 ± 53.0 | 279.6 ± 50.1 | 0.22 | 0.70 | 0.73 |
| Nasal | 272.9 ± 60.8 | 265.0 ± 66.1 | 247.7 ± 51.5 | 0.73 | 0.76 | 0.85 |
| Inferior | 291.6 ± 67.5 | 280.6 ± 62.3 | 275.3 ± 45.3 | 0.72 | 0.87 | 0.91 |
| Temporal | 297.7 ± 57.2 | 292.3 ± 61.5 | 293.1 ± 54.8 | 0.98 | 0.96 | 0.93 |
| Outer ring (3-6 mm) | ||||||
| Superior | 270.3 ± 39.8 | 278.6 ± 49.1 | 265.0 ± 48.8 | 0.53 | 0.49 | 0.92 |
| Nasal | 220.3 ± 56.5 | 215.3 ± 60.2 | 185.7 ± 46.7 | 0.80 | 0.22 | 0.41 |
| Inferior | 272.8 ± 55.9 | 267.0 ± 61.3 | 260.4 ± 42.9 | 0.79 | 0.94 | 0.77 |
| Temporal | 287.9 ± 51.8 | 291.7 ± 59.5 | 286.6 ± 54.2 | 0.86 | 0.86 | 0.72 |
| Center 6 mm | 268.1 ± 44.3 | 267.6 ± 50.8 | 255.7 ± 44.9 | 0.996 | 0.59 | 0.96 |
AE: Amblyopic eyes; FE: Fellow eyes; NE: Normal control eyes; SFCT: subfoveal choroidal thickness; ETDRS: early treatment diabetic retinopathy study; AL: axial length
a ANCOVA; ** p < 0.01; * p < 0.05
Values are shown as mean ± standard deviation (μm)